Respiratory
Beximco Pharma is the leading manufacturer of pressurized Metered Dose Inhalers (MDI) in Bangladesh and are among the few companies in the world manufacturing CFC (Chlorofluorocarbon) free MDIs. It has a wide range of inhalers 'Reliever', 'Preventer' and 'Controller' for the treatment of asthma and COPD. The company also undertakes contract manufacturing for GlaxoSmithKline for its 'reliever' brand. In collaboration with Europe's one of the leading manufacturers of specialty medical devices and respiratory drug development companies, Beximco Pharma successfully developed and introduced country's fist CFC-free HFA based MDIs in September 2006.
Aeronid HFA
Budesonide 200 mcg inhalation aerosol
Aeronid® is a preperation of Budesonide,which is a glucocorticoid steroid that have potent anti-inflammatory actions that reduces inflammation and hyper-reactivity (spasm) of the airways caused by asthma. When used as an inhaler, the budesonide goes directly to the inner lining of the inflamed airways to exert its effects. Aeronoid is safe to be used in pregnancy & for children.
Azmasol
(Salbutamol 100 mcg/actuation)
Azmasol®, is a short-acting bronchodilator which keeps the bronchial tubes in the lungs open and relieves the symptoms of asthma and other chest conditions.Azmasol® is useful as the treatment of activity-induced bronchospasm in asthma attacks & COPD.
Azmasol HFA
( Salbutamol BP as sulfate )
Azmasol® HFA inhaler is an environment friendly, CFC-free inhaler. It contains Salbutamol BP (as sulfate) as the active ingredient which is a 2- adrenoceptor agonist used in the treatment of asthma and other forms of diffuse reversible airways obstruction. It is indicated for the treatment and prophylaxis of bronchial asthma and for the treatment of reversible airways obstruction associated with bronchitis and emphysema. it is also (Salbutamol) inhaler may be used to relieve attacks of acute dyspnoea and be taken prophylactically before exertion or to prevent exercise-induced asthma
Bexitrol
( Salmeterol actuation )
Bexitrol inhaler is a preperation of Salmeterol which is a long acting beta 2 agonist and bronchodilator (inhalation) medication commonly used to prevent and treat the symptoms in people with mild to moderate asthma.long acting beta -2 agonist helps in the prevention of nocturnal asthma attack
Bexitrol F
( Salmeterol Xinafoate 25 mcg + Fluticasone Propionate 50/125/250 mcg
HFA Inhalation Aerosol )
Bexitrol-F CFC free inhaler is a metered dose inhaler (MDI) contains two medicines, Salmeterol Xinafoate and Fluticasone Propionate. Salmeterol Xinafoate is a selective, long acting b2 agonist acts as bronchodilator. Fluticasone Propionate is a corticosteroid with mainly glucocorticoid activity. It reduces swelling and irritation in the lungs. It is environment friendly inhaler which contains ozone-benign propellant replacing CFC propellant. Bexitrol F is indicated in the regular treatment of asthma where use of a combination product (long acting b2 agonist and inhaled corticosteroid) is appropriate: 1. Patients not adequately controlled with inhaled corticosteroids and with "as needed" inhaled short acting b2 agonist or 2. Patients already adequately controlled on both inhaled corticosteroids and long acting b2 agonist.
Bexitrol F
( Salmeterol Xinafoate and Fluticasone Propionate )
Salmeterol Xinafoate is a selective, long acting b2 agonist used in the treatment of asthma and other forms of diffuse airways obstruction. Fluticasone Propionate is a corticosteroid with mainly glucocorticoid activity. Fluticasone Propionate is stated to exert a topical effect on the lungs without systemic effects at usual dose. Bexitrol-F combines both ingredients in single inhaler. Bexitrol F is indicated in the regular treatment of asthma where use of a combination product (long acting b2 agonist and inhaled corticosteroid) is appropriate: 1. Patients not adequately controlled with inhaled corticosteroids and with "as needed" inhaled short acting b2 agonist or 2. Patients already adequately controlled on both inhaled corticosteroids and long acting b2 agonist.
Bricasol
Terbutaline Sulfate USP 5 mg/2 ml
Respirator Solution
It is a selective β2-adrenergic agonist used as a bronchodilator and tocolytic. Terbutaline appears to have a greater stimulating effect on β -receptors of the bronchial, vascular and uterine smooth muscles (b2-receptors) than on the β -receptors of the heart (β1-receptors). This drug relaxes smooth muscle and inhibits uterine contractions, but may also cause some cardio-stimulatory effects and CNS stimulation.
- Successfully open ups the airways.
- Effectively relieves trouble breathing upon exertion.
- Prevents bronchospasm in patients 12 years of age and older with reversible, obstructive airway disease.
- Provides symptomatic management of reversible bronchospasm associated with bronchitis and emphysema.
Cesonide
( Ciclesonide inhalation )
Cesonide® contains ciclesonide is a new generation inhaled corticosteroid for asthma. It is indicated for the treatment to control persistent asthma in adults (18 years and older).
Decomit HFA
( Decomit Dipropionate )
Decomit® HFA is a metered dose inhaler (MDI) contains beclomethasone dipropionate. It is environment friendly inhaler which contains ozone-benign propellant replacing CFC propellant. Decomit HFA is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Beclomethasone dipropionate is also indicated for asthma patients who require systemic corticosteroid administration, where adding Beclomethasone dipropionate may reduce or eliminate the need for the systemic corticosteroids.
Ipramid
( Ipratropium Bromide BP 20 mcg/ actuation )
Ipramid is a preperation of Ipratropium bromide which is a anticholinergic agent that works as a bronchodilator that dilates the bronchi in the lungs. It is used in treating chronic obstructive pulmonary disease associated with chronic bronchitis and emphysema. In chronic obstructive pulmonary disease, cholinergic nerves going to the lungs cause narrowing of the bronchi by stimulating the muscles surrounding the bronchi to contract. An "anti-cholinergic" effect of ipratropium bromide blocks the effect of the cholinergic nerves, causing the muscles to relax and the bronchi to dilate.
Ipramid HFA
Ipratropium Bromide BP 20 mcg inhalation aerosol
Ipramid is a preperation of Ipratropium bromide which is a anticholinergic agent that works as a bronchodilator that dilates the bronchi in the lungs. It is used in treating chronic obstructive pulmonary disease associated with chronic bronchitis and emphysema. In chronic obstructive pulmonary disease, cholinergic nerves going to the lungs cause narrowing of the bronchi by stimulating the muscles surrounding the bronchi to contract. An "anti-cholinergic" effect of ipratropium bromide blocks the effect of the cholinergic nerves, causing the muscles to relax and the bronchi to dilate.
Iprasol
( Salbutamol 100 mcg & Ipratropium Bromide BP 20 mcg /actuation )
Iprasol is a preparation of Salbutamol & Ipratropium bromide.Salbutamol is a beta2-adrenergic agent which acts on airway smooth muscle resulting in relaxation. Ipratropium Bromide is a anticholinergic agent that works as a bronchodilator that dilates the bronchi in the lungs. Iprasol provides the simultaneous release of ipratropium bromide and salbutamol allowing the synergistic efficacy on the muscarinic and beta2-adrenergic receptors in the airways to cause bronchodilation which is superior to that provided by each single agent and with no potentiation of adverse events.
Iprasol HFA
(Salbutamol 100 mcg + Ipratropium Bromide BP 20 mcg inhalation aerosol)
Iprasol is a preperation of Salbutamol & Ipratropium bromide.Salbutamol is a beta2-adrenergic agent which acts on airway smooth muscle resulting in relaxation. Ipratropium Bromide is a anticholinergic agent that works as a bronchodilator that dilates the bronchi in the lungs. Iprasol provides the simultaneous release of ipratropium bromide and salbutamol allowing the synergistic efficacy on the muscarinic and beta2-adrenergic receptors in the airways to cause bronchodilation which is superior to that provided by each single agent and with no potentiation of adverse events.
Monocast
( Montelukast Tablet )
Monocast is indicated for the prophylaxis and chronic treatment of asthma in adults and paediatric patients 12 months of age and older. Monocast is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and paediatric patients 2 years of age and older.
Mucomist
(Acetylcysteine USP 200 mg/ ml
Solution for inhalation (not for injection)
Mucomist® Respirator Solution is a derivative of the amino acid, cysteine. It acts mostly on the mucoproteins, through its free sulphydryl groups, to open disulphide bonds and lower the viscosity of the mucus. Furthermore, acetylcysteine exerts an antioxidant action by interacting directly with the oxidant radicals. The action of acetylcysteine in limiting hepatotoxicity after paracetamol (acetaminophen) overdosage is probably due to the replenishing of hepatic stores of glutathione.
Nasomet
(Mometasone Furoate )
Nasomet (Mometasone) is a corticosteroid demonstrating anti-inflammatory properties. The precise mechanism of corticosteroid's action on allergic rhinitis is not known. Corticosteroids have been shown to have a wide range of effects on multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, and cytokines) involved in inflammation.
Nazolin
( Oxymetazoline Hydrochloride Nasal Spray )
Oxymetazoline Hydrochloride, the active ingredient of Nazolin® nasal spray, is a sympathomimetic amine of the imidazoline class. Nazolin® is indicated for the following purposes as a nasal decongestant in allergic rhinitis, with or without the addition of topical antihistamines or sodium cromoglycate; as a nasal decongestant in sinusitis where there is evidence of obstruction of ostea to the sinuses; as nasal decongestant in otitis media where there is evidence of obstruction of eustachian tube, especially in subacute serous otitis media (glue ear) and otitic barotrauma; as a decongestant in an infective rhinitis(e.g. an acute viral upper respiratory tract infection). where there is a secondary bacterial infection, there is no evidence of benefit.
Perinase
( Fluticasone Propionate Nasal Spray )
Perinase® nasal spray is an aqueous suspension of microfine Fluticasone Propionate for topical administration to the nasal mucosa by means of a metering, atomizing spray pump. The active ingredient Fluticasone Propionate is a synthetic corticosteroid.Perinase® nasal spray is indicated for the management of the nasal symptoms of seasonal and perennial allergic and nonallergic rhinitis in adults and pediatric patients 4 years of age and older.
Respira
( Levosulbutamol 1 mg & 2 mg tablet, syrup & inhaler )
Respira® is a preparation of Levosulbutamol sulphate. It is a beta 2 agonist and indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 4 years of age and older with reversible obstructive airway disease.
Symbion Bexicap
Dry Powder Inhaler
Formoterol Fumarate Dihydrate and Budesonide Capsule
Formoterol is a very potent, long-acting, beta2 adrenoceptor-agonist with a high intrinsic activity and a rapid onset of action. Symbion® Bexicap capsule is a combination of Formoterol Fumarate Dihydrate and Budesonide. Budesonide is a potent glucocorticoid that binds with high affinity to the glucocorticoid receptor. It has a high ratio of topical to systemic activity.
Page 1 of 2
Welcome to the registered Health Professionals, to this exclusive Doctors only area. This provides you access to latest medical updates, events, guidelines and information relevant to your practice. If you are not a registered doctor please do not enter this area. 
Life's all about staying healthy and enjoying the good things in life! However, illness is inevitable at all stages of life. In this area learn about the common health problems and how to deal with your and your family's illness.